Literature DB >> 16033981

Evidence for recombination in Crimean-Congo hemorrhagic fever virus.

Alexander N Lukashev1.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) virus has attracted considerable attention recently and a number of phylogenetic studies have been published, based mostly on partial sequences of S and M RNA segments. In this study, available full-length S, M and L segment sequences of CCHF virus were checked for recombination. Similarity plots and bootscan analysis of the S segment suggested multiple recombination events between southern European, Asian and African CCHF virus strains, with additional evidence provided by phylogenetic trees, the hidden Markov model and probabilistic divergence measures methods. No unambiguous signs of recombination were observed for M and L segments; however, the results did not exclude the possibility of this. These findings, coupled with a recent report on reassortment in CCHF virus, suggest caution when assessing CCHF virus phylogeny based on short sequence fragments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033981     DOI: 10.1099/vir.0.80974-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Authors:  Varough M Deyde; Marina L Khristova; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

3.  A nosocomial transmission of crimean-congo hemorrhagic fever to an attending physician in North Kordufan, Sudan.

Authors:  Afraa T Elata; Mubarak S Karsany; Rehab M Elageb; Marwa A Hussain; Kamal H Eltom; Mustafa I Elbashir; Imadeldin E Aradaib
Journal:  Virol J       Date:  2011-06-15       Impact factor: 4.099

4.  Multiple Crimean-Congo hemorrhagic fever virus strains are associated with disease outbreaks in Sudan, 2008-2009.

Authors:  Imadeldin E Aradaib; Bobbie R Erickson; Mubarak S Karsany; Marina L Khristova; Rehab M Elageb; Mohamed E H Mohamed; Stuart T Nichol
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

Review 5.  Homologous recombination in negative sense RNA viruses.

Authors:  Guan-Zhu Han; Michael Worobey
Journal:  Viruses       Date:  2011-08-04       Impact factor: 5.048

6.  Next-generation sequencing of southern African Crimean-Congo haemorrhagic fever virus isolates reveals a high frequency of M segment reassortment.

Authors:  D Goedhals; P A Bester; J T Paweska; R Swanepoel; F J Burt
Journal:  Epidemiol Infect       Date:  2014-05-01       Impact factor: 4.434

7.  The complete genomic sequence of strain ROS/HUVLV-100, a representative Russian Crimean Congo hemorrhagic fever virus strain.

Authors:  John D Meissner; Sergey S Seregin; Sergei V Seregin; Oleg I Vyshemirskii; Nina V Yakimenko; Sergei V Netesov; Vladimir S Petrov
Journal:  Virus Genes       Date:  2006-08       Impact factor: 2.198

8.  Crimean-Congo hemorrhagic fever virus clades V and VI (Europe 1 and 2) in ticks in Kosovo, 2012.

Authors:  Kurtesh Sherifi; Daniel Cadar; Skender Muji; Avni Robaj; Salih Ahmeti; Xhevat Jakupi; Petra Emmerich; Andreas Krüger
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

9.  New genotypes of Orientia tsutsugamushi isolated from humans in Eastern Taiwan.

Authors:  Hui-Hua Yang; I-Tsong Huang; Chin-Hui Lin; Tren-Yi Chen; Li-Kuang Chen
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo.

Authors:  Darja Duh; Stuart T Nichol; Marina L Khristova; Ana Saksida; Iva Hafner-Bratkovic; Miroslav Petrovec; Iusuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Virol J       Date:  2008-01-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.